CN104404073A - Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules - Google Patents

Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules Download PDF

Info

Publication number
CN104404073A
CN104404073A CN201410593851.1A CN201410593851A CN104404073A CN 104404073 A CN104404073 A CN 104404073A CN 201410593851 A CN201410593851 A CN 201410593851A CN 104404073 A CN104404073 A CN 104404073A
Authority
CN
China
Prior art keywords
dna
mutation
test kit
fidelity
template
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410593851.1A
Other languages
Chinese (zh)
Inventor
蒋国成
陈旭
陈刚
佟勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Technology (taicang) Co Ltd
Original Assignee
Bio Technology (taicang) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology (taicang) Co Ltd filed Critical Bio Technology (taicang) Co Ltd
Priority to CN201410593851.1A priority Critical patent/CN104404073A/en
Publication of CN104404073A publication Critical patent/CN104404073A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a mutation kit based on methylation circular DNA molecules. The kit comprises methylation circular DNAs, a mutation primer with mutation sites, high-fidelity heat-resisting DNA polymerases, high-temperature DNA ligases, restrictive incision enzymes DpnI and competent cells. The invention further relates to application and a using method of the kit. By means of the kit, single point mutation can be achieved, and one-step multipoint mutation can be achieved; in addition, operation is simple, the mutation rate is high, the single point mutation positive rate is higher than 95%, and the mutation positive rate of two points or three points which are at a distance of 1kb is higher than 60%.

Description

A kind of mutagenesis kit based on the ring-shaped DNA molecule that methylates and application thereof
Technical field
The present invention relates to technical field of molecular biology, specifically, relate to a kind of mutagenesis kit based on the ring-shaped DNA molecule that methylates and application thereof.
Background technology
External site-directed mutagenesis technique is the important laboratory facilities of one in current biological, each area research of medical science, it is the convenient solution of transformation, optimized gene, being the effective means exploring promotor regulatory site, is also the powerful of the complex relationship between Study on Protein structure and function.
Carry out fixed point to the particular bases of certain known to change, lack or insert, corresponding aminoacid sequence and protein structure can be changed, and then change the function of protein.The potential Application Areas of site-directed mutagenesis technique is very wide, the structure in such as Way for Studying Protein-Protein Interactions site, the different activities of transformation enzyme or dynamics, transformation promotor or DNA functional element, introduce new restriction enzyme site, improve the crystalline structure of the antigenicity of albumen or stability, activity, research albumen, and the aspect such as medicament research and development, gene therapy.Current directed mutagenesis method mainly contains the rite-directed mutagenesis of Oligonucleolide primers mediation, rite-directed mutagenesis, the cassette mutagenesis of PCR mediation.
The rite-directed mutagenesis of Oligonucleolide primers mediation, first will be cloned in M13 phage vector containing the DNA fragmentation needing to be suddenlyd change.The normal chain of M13 phage can go to infect the bacterium with sex pili, and after copying in bacterial body, forms the new phage with positive chain DNA with the form of sprouting.Being deposited in intraphagic, is the replicability M13 of double-stranded state, and the bacterial growth infected by M13 slows down, and Micro-Organism Culture Dish can form transparent plaque.Target DNA is inserted in the multiple clone site of rf M13, removes infect bacteria, extract the template of single stranded DNA as sudden change.Synthesize the oligonucleotide primer with mutant nucleotide sequence as required, make it to hybridize with the strand M13 template with target DNA, then archaeal dna polymerase and four kinds of deoxyribonucleotides are added, mutant primer in hybridization is extended, and make the DNA of new synthesis become ring with DNA ligase, then remove infect bacteria.Available DNA sequence analysis method filters out with the corresponding fragment of mutant DNA from the phage obtained, thus obtains complete DNA mutation body.
The rite-directed mutagenesis of PCR mediation utilizes four kinds of primers, and carry out the PCR reaction of three-wheel, wherein head two-wheeled amplifies the DNA fragmentation overlapped each other respectively, and third round PCR makes this two bar segment merge.It is in the PCR of front two-wheeled, apply two complementary and there is in same area the inner primer of identical base mutation, the double chain DNA fragment that amplification formation two has one end to overlap each other, both have identical sudden change at its overlap section.Owing to having overlapping sequence, so after eliminating the excess primers do not participated in, these two double chain DNA fragments, through sex change and anneal, just may form two kinds of multi-form heteroduplex molecules.Wherein a kind of tool 5 ,the duplex molecule of recessed ends, can not as the substrate of Taq DNA polymerase; Another kind has 3 ,the duplex molecule of recessed ends, by the progradation of Taq DNA polymerase, produces the double chain DNA molecule providing double folded sequence.This DNA molecular carries out third round pcr amplification with two outside Oligonucleolide primers again, partially can produce the mutant DNA of a kind of mutational site away from fragment ends.
Cassette mutagenesis is the oligonucleotide fragment containing transgenation sequence utilizing one section of synthetic, replaces the corresponding sequence in wild type gene.The oligonucleotide of this sudden change is made up of two oligonucleotide, and when they are annealed, produce the sticky end of clone's needs by design requirements, owing to there is not the intermediate of heteroduplex, therefore recombinant plasmid is all mutant.If be inserted into by the mutant oligonucleotide of degeneracy on plasmid vector molecule, in experiment once, just can obtain the mutant of One's name is legion, greatly reduce the number of times that sudden change needs.
Three kinds of methods respectively have advantage, and oligonucleotide mediated method fidelity of reproduction is high; The method of PCR mediation is simple to operate, is mutated into power high; Boxlike method is simple, and mutation efficiency is high.But they also also exist very large shortcoming separately, oligonucleotide mediated method complicated operation, the cycle is long; The method follow-up work of PCR mediation is complicated, and Taq DNA polymerase fidelity is low; It is high that boxlike method need synthesize many primer costs, is subject to the restriction of restriction enzyme site.
In sum, need badly a kind of simple to operate, fidelity good, and can realize method and the test kit of a step multipoint mutation, but have not been reported about this method and test kit at present.
Summary of the invention
The object of the invention is for deficiency of the prior art, a kind of site-directed mutagenesis kit based on the ring-shaped DNA molecule that methylates is provided.
The present invention again one object be that the application of described test kit is provided.
Another object of the present invention provides the using method of described test kit.
For realizing above-mentioned first object, the technical scheme that the present invention takes is:
A kind of site-directed mutagenesis kit based on the ring-shaped DNA molecule that methylates, described test kit comprises: methylate cyclic DNA, the mutant primer in band mutational site, the hot resistant DNA polymerase of high-fidelity and high temperature DNA ligase, restriction enzyme Dpn I, competent cell.
The hot resistant DNA polymerase of described high-fidelity is Phusion High-Fidelity DNA Polymerase.
Described high temperature DNA ligase is Taq DNA Ligase ligase enzyme or 9 ° of N DNA ligases.
The mutant primer in described band mutational site is the wall scroll primer that cyclic DNA is stencil design that methylates, and respectively before and after mutational site retains 16 ~ 20 bases of matching with template.
Described test kit also comprises reaction buffer, GC reaction buffer, dNTP, ATP, NAD+.
For realizing above-mentioned second object, the technical scheme that the present invention takes is:
As above the arbitrary described application of test kit in rite-directed mutagenesis.
Described rite-directed mutagenesis is simple point mutation or multipoint mutation.
For realizing above-mentioned 3rd object, the technical scheme that the present invention takes is:
As above the using method of arbitrary described test kit, comprises the following steps:
A) PCR reaction obtains the circular ssdna with specific sudden change: with the cyclic DNA that methylates for template, use the mutant primer in band mutational site, adopts the hot resistant DNA polymerase of high-fidelity and high temperature DNA ligase to increase;
B) PCR primer of step a) is used restriction enzyme Dpn I digestion, remove the template that methylates;
C) proceed in competent cell by the digestion product in step b), the described single-stranded cyclic DNA reparation with specific sudden change is the circular double stranded DNA with specific sudden change, finally obtains the plasmid after suddenling change.
The hot resistant DNA polymerase of described high-fidelity and the adding proportion of high temperature DNA ligase enzyme are: enzyme activity unit compares 1:60.
Use the time of restriction enzyme Dpn I digestion be 5 minutes to spending the night; Described digestion product directly proceeds in competent cell.
It should be noted that, in the present invention, the template of PCR reaction must methylate, if not methylated DNA profiling, first can transform the coli strain extracting acquisition again of dam+; Adopt high purity as far as possible, plasmid that concentration is approximately 50 ~ 100 ng/ μ l; If template is greater than 15 kb, required mutant nucleotide sequence need be subcloned in less carrier and implements.Described its fidelity performance of Phusion High-Fidelity DNA Polymerase and amplification efficiency all good.
The invention has the advantages that: the invention provides a kind of new site-directed mutagenesis kit, this mutagenesis kit not only has the function of common rite-directed mutagenesis, and when running into the demand of multiple site mutation, also can realize a step multipoint mutation, solve common simple point mutation and can only introduce sudden change one by one to target site, the problem of time and effort consuming, and it is simple to operate, mutation rate is high, simple point mutation positive rate more than 95%, at a distance of more than 1kb two point, three point mutation positive rates more than 60%.
Accompanying drawing explanation
Accompanying drawing 1 is principle of the present invention and operation schematic diagram.
Accompanying drawing 2 is 3 single bacterium colony order-checking comparison result figure in embodiment 1 after amino acid mutation.
Accompanying drawing 3 is amino acid mutation 3 bacterium colony order-checking parent mass peak figure in embodiment 1.
Accompanying drawing 4 is design of primers citings.
Accompanying drawing 5 is primary template sequence and design rear sudden change primer sequence comparison charts before design of primers.
Embodiment
Below in conjunction with accompanying drawing, embodiment provided by the invention is elaborated.
Applying the general thought that mutagenesis kit of the present invention carries out rite-directed mutagenesis is: preparation methylates template, a mutant primer is only synthesized for each targeted mutagenesis, recycling fidelity performance and all good hot resistant DNA polymerase of amplification efficiency, the single-stranded cyclic DNA with specific sudden change (30 sec/1 kb) of Fast back-projection algorithm and template complementation, keep the fidelity of amplification plasmid to greatest extent, Reaction time shorten greatly.After multiple PCR circulating reaction, the single-stranded cyclic DNA number with specific sudden change is doubled and redoubled.After PCR reaction terminates, adopt restriction enzyme Dpn I to digest methylated template, the single-stranded cyclic DNA with sudden change then passes through transformation of E. coli body, repairs as circular double stranded DNA, finally obtain the DNA plasmid with sudden change group in its body.
One, reagent prepares
The preparation of mixed enzyme of 1, suddenling change: 2 U/ μ l Phusion High-Fidelity DNA Polymerase (NEB M0530) prepare according to volume ratio 1:3 with 40U/ μ l Taq DNA Ligase ligase enzyme (NEB M0208) or 40U/ μ l 9 ° of N DNA ligase enzymes (NEB M0238), if the mutant enzyme preparing 10 times adds Taq DNA Ligase ligase enzyme or 9 ° of N DNA ligases of 7.5 μ l with the Phusion High-Fidelity DNA Polymerase of 2.5 μ l.
2, suddenly change dNTP preparation: 10mM dNTP Mix(EXCELL MB021-0014) 2.5 μ l, 50 μMs of β-Nicotinamide adenine dinucleotide (NAD+) (NEB B9007) 5 μ l, sterilizing distilled water 2.5 μ l; Or 10mM dNTP Mix(EXCELL MB021-0014) 2.5 μ l, 10 μMs of ATP (NEB P0756) 5 μ l, sterilizing distilled water 2.5 μ l.
3,5 × Buffer that the buffer Phusion enzyme that suddenlys change carries.
4, template digestion enzyme is with FastDigest Dpn I (MBI FD1704).
Two, template prepares
1) plasmid of 15 below kb please be use as template; If template plasmid is excessive, the sequence of required sudden change can be subcloned in less carrier, be cloned in object carrier after completing sudden change again; Or symmetric position designs one and completes sudden change with the primer of template complete complementary nearly.
2) for non-methylated plasmid (plasmid such as extracted from intestinal bacteria JM110 or SCS110 bacterial strain), by transforming the coli strain (as DH5 α, TOP10, JM109, XL1 Blue etc.) of dam+, then extracting obtains methylated plasmid as PCR reaction template.
3) adopt highly purified template plasmid, concentration is adjusted to 50 ~ 100 ng/ μ l as far as possible.
Three, design of primers principle
1) before and after suddenlyd change base, need the base of each reservation 16 ~ 20 and template complementation;
2) design of multiple mutant primer with the same chain of plasmid for template, must extend to same direction;
3) if two or more primer in same reaction in, the distance between their mutational sites need at 60 more than bp.If the spacing of two primers is within 60 bp, just needs to carry out two reactions and carry out PCR.After the PCR of a primer completes, carry out next PCR reaction using adding another primer as template after PCR primer extracting wherein.If there is the mutational site of more than 5, two PCR reactions should be carried out;
4) the 3' end of primer should comprise at least one G or C base, avoids the repetition base of more than three, in order to avoid mispairing as far as possible;
5) the GC content of primer is controlled 40 ~ 60% as far as possible;
6) primer through PAGE or HPLC purifying please be use, otherwise sudden change positive rate can be reduced.
Fig. 4 is shown in design of primers citing.
Four, rite-directed mutagenesis reaction
1) PCR reaction system: add following reagent successively in PCR thin-walled tube:
Experimental group:
The plasmid template higher to GC content, can use GC Reaction Buffer.
2) mixing after add 1 μ l suddenly change mixed enzyme, mixing, of short duration centrifugal after put into PCR instrument.
3) setting of PCR loop parameter:
Annealing temperature depends on Tm value minimum in multiple primer;
Such as: the time that 5 kb plasmids extend is 2.5 min;
15 cycles: single base mutation;
18 cycles: the sudden change of single amino acids (three continuous bases);
>=18 cycles: multiple site mutation.
Five, question response is cooled to after below room temperature, adds 1 μ l Dpn I enzyme, of short duration centrifugal after mixing, 37 DEG C of incubations 5 minutes (also can react and spend the night).Can conversion be directly used in after Dpn I enzymic digestion, or in DEG C to save backup.
Six, transform, cultivate
1) thaw competent cell, and thawing condition is water-bath 25 DEG C, 35 seconds, or in beaker (room temperature water) or tap water pipe shaft, observe ice crystal to thaw more than 1/2 or entirely molten nearly, but to before having operated painting flat board after thawing, be inserted in as far as possible and avoid mistake temperature to cause deterioration of efficiency on ice;
2) the postdigestive DNA of 1.5 μ l is added;
3) 1000 ~ 1200 rpm whirlpool mixing 1 ~ 2 second;
4) ice bath: the competent cell homogeneous tube adding DNA is inserted in ice and leaves standstill 5 min;
5) heat shock: competent cell is put into after ice bath water bath and do heat shock in 45 seconds with 42 DEG C of water-baths;
6) transfection mixture is coated containing (if color examination can contain IPTG and X gal if required) on appropriate antibiotic LB agar plate;
7) by flat board in 37 DEG C of overnight incubation.To carry out blue hickie examination, then at least cultivate 17 hours at 37 DEG C, so that the formation of color spot.
Seven, identify: according to the complexity of sudden change, a peek single bacterium colony checks order, to confirm whether the clone obtained contains the mutant nucleotide sequence of expection.For the sudden change bacterium colony inserting restriction endonuclease sites, directly can select about 10 mono-clonal bacterium colonies and cultivate, extraction plasmid carries out enzyme and cuts qualification.
embodiment 1
One, reagent prepares
The preparation of mixed enzyme of 1, suddenling change: the Phusion High-Fidelity DNA Polymerase preparing the mutant enzyme 2.5 μ l of 10 times adds the Taq DNA Ligase ligase enzyme mixing of 7.5 μ l.
2, suddenly change dNTP preparation: 10mM dNTP Mix(EXCELL MB021-0014) 2.5 μ l, 50 μMs of β-Nicotinamide adenine dinucleotide (NAD+) (NEB B9007) 5 μ l, sterilizing distilled water 2.5 μ l.
3,5 × Buffer that the buffer Phusion enzyme that suddenlys change carries.
4, template digestion enzyme is with FastDigest Dpn I (MBI FD1704).
Two, template prepares
1) to do for template with the ORIGENE company article No. plasmid (length is about 8.5kb) that is Cat. RG215266 and suddenly change.
2) with the Host Strains of DH5 α for Cat. RG215266 plasmid, and training method is cultivated this bacterium extracting and to be methylated plasmid template routinely.
3) JaRa biological plasmid extraction agent box (GK2001) extracting plasmid is adopted.
Three, design of primers
Be KV4.2 gene the 529th cysteine mutation expressed in the plasmid original series of Cat. RG215266 by above-mentioned ORIGENE company article No. be L-Ala, design of primers is as follows:
Primer529:aggagtcaccagcaccGCctgttcacgacgacac
Before design, Fig. 5 is shown in primary template sequence and the comparison of design rear sudden change primer sequence.
Four, rite-directed mutagenesis reaction
1) the present embodiment the 529th cysteine mutation is that L-Ala reaction system is as follows:
Template Plasmid 1μl(100ng)
5×Reaction Buffer 5μl
Primer529(10μM) 1μl
Sudden change dNTP 1 μ l
ddH 2O 16μl
2) mixing after add 1 μ l suddenly change mixed enzyme, mixing, of short duration centrifugal after put into PCR instrument.
3) setting of PCR loop parameter:
Five, question response is cooled to after below room temperature, adds 1 μ l Dpn I enzyme, of short duration centrifugal after mixing, 37 DEG C of incubations 5 minutes.Can conversion be directly used in after Dpn I enzymic digestion, or in DEG C to save backup.
Six, transform, cultivate
1) thaw competent cell XL10-Gold(ExCell MB000-5321), thawing condition is water-bath 25 DEG C, 35 seconds;
2) the postdigestive DNA of 1.5 μ l is added;
3) 1000 rpm whirlpools mix 2 seconds;
4) ice bath: the competent cell homogeneous tube adding DNA is inserted in ice and leaves standstill 5 min;
5) heat shock: competent cell is put into after ice bath water bath and do heat shock in 45 seconds with 42 DEG C of water-baths;
6) being coated by transfection mixture containing final concentration is on the ammonia benzyl microbiotic LB agar plate of 50ug/ml;
7) by flat board in 37 DEG C of overnight incubation.
Seven, identify:
Get 30 single bacterium colony order-checkings after the present embodiment amino acid mutation, sequencing result display positive rate is 100%, and wherein 3 bacterium colony order-checking comparison results are shown in accompanying drawing 2.Wherein 3 bacterium colony order-checking parent mass peak figure the results are shown in accompanying drawing 3.This experiment is repeated 10 times, and positive rate is 100%.
Present patent application is subject to following two gene supports: Shanghai City Nsfc Projects (10ZR1439900), and granary scientific and technical innovation is started an undertaking leading talent's project (TCRC1306).
The above is only the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the prerequisite not departing from the inventive method; can also make some improvement and supplement, these improve and supplement and also should be considered as protection scope of the present invention.
SEQUENCE LISTING
<110> Yi Kesai biotechnology (granary) company limited
<120> mutagenesis kit based on the ring-shaped DNA molecule that methylates and application thereof
<130> /
<160> 8
<170> PatentIn version 3.3
<210> 1
<211> 35
<212> DNA
<213> artificial sequence
<400> 1
ctagacgcgc cctgtagcgg cgcattaagc gcacg 35
<210> 2
<211> 35
<212> DNA
<213> artificial sequence
<400> 2
ctagacgcgc cctgtaacga cgcattaagc gcacg 35
<210> 3
<211> 34
<212> DNA
<213> artificial sequence
<400> 3
aggagtcacc agcaccgcct gttcacgacg acac 34
<210> 4
<211> 47
<212> DNA
<213> artificial sequence
<400> 4
caaggagtca ccagcacctg ctgttcacga cgacacaaaa aaacttt 47
<210> 5
<211> 47
<212> DNA
<213> artificial sequence
<400> 5
caaggagtca ccagcaccks ctgttcacga cgacacaaaa aaacttt 47
<210> 6
<211> 34
<212> DNA
<213> artificial sequence
<400> 6
gtgtcgtcgt gaacaggcgg tgctggtgac tcct 34
<210> 7
<211> 54
<212> DNA
<213> artificial sequence
<400> 7
agtttttttg tgtcgtcgtg aacagcaggt gctggtgact ccttgttgtg aaga 54
<210> 8
<211> 54
<212> DNA
<213> artificial sequence
<400> 8
agtttttttg tgtcgtcgtg aacaggcggt gctggtgact ccttgttgtg aaga 54
 

Claims (10)

1. based on a site-directed mutagenesis kit for the ring-shaped DNA molecule that methylates, it is characterized in that, described test kit comprises: methylate cyclic DNA, with the mutant primer in mutational site, the hot resistant DNA polymerase of high-fidelity and high temperature DNA ligase, restriction enzyme Dpn I, competent cell.
2. test kit according to claim 1, is characterized in that, the hot resistant DNA polymerase of described high-fidelity is Phusion High-Fidelity DNA Polymerase.
3. test kit according to claim 1, is characterized in that, described high temperature DNA ligase is Taq DNA Ligase ligase enzyme or 9 ° of N DNA ligases.
4. test kit according to claim 1, is characterized in that, the mutant primer in described band mutational site is the wall scroll primer that cyclic DNA is stencil design that methylates, and respectively before and after mutational site retains 16 ~ 20 bases of matching with template.
5. test kit according to claim 1, is characterized in that, described test kit also comprises reaction buffer, GC reaction buffer, dNTP, ATP, NAD+.
6. the arbitrary described application of test kit in rite-directed mutagenesis of claim 1-5.
7. application according to claim 6, is characterized in that, described rite-directed mutagenesis is simple point mutation or multipoint mutation.
8. the using method of the arbitrary described test kit of claim 1-5, is characterized in that, comprise the following steps:
A) PCR reaction obtains the circular ssdna with specific sudden change: with the cyclic DNA that methylates for template, use the mutant primer in band mutational site, adopts the hot resistant DNA polymerase of high-fidelity and high temperature DNA ligase to increase;
B) PCR primer of step a) is used restriction enzyme Dpn I digestion, remove the template that methylates;
C) proceed in competent cell by the digestion product in step b), the described single-stranded cyclic DNA reparation with specific sudden change is the circular double stranded DNA with specific sudden change, finally obtains the plasmid after suddenling change.
9. using method according to claim 8, is characterized in that, the hot resistant DNA polymerase of described high-fidelity and the adding proportion of high temperature DNA ligase enzyme are: enzyme activity unit compares 1:60.
10. using method according to claim 8, is characterized in that, use the time of restriction enzyme Dpn I digestion be 5 minutes to spending the night; Described digestion product directly proceeds in competent cell.
CN201410593851.1A 2014-10-30 2014-10-30 Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules Pending CN104404073A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410593851.1A CN104404073A (en) 2014-10-30 2014-10-30 Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410593851.1A CN104404073A (en) 2014-10-30 2014-10-30 Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules

Publications (1)

Publication Number Publication Date
CN104404073A true CN104404073A (en) 2015-03-11

Family

ID=52641739

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410593851.1A Pending CN104404073A (en) 2014-10-30 2014-10-30 Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules

Country Status (1)

Country Link
CN (1) CN104404073A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1519326A (en) * 2003-01-30 2004-08-11 中国科学院动物研究所 Method of point mutation without need of chain reaction of polymerase and the kit
CN102695795A (en) * 2009-12-21 2012-09-26 图尔库大学 Mutagenesis method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1519326A (en) * 2003-01-30 2004-08-11 中国科学院动物研究所 Method of point mutation without need of chain reaction of polymerase and the kit
CN102695795A (en) * 2009-12-21 2012-09-26 图尔库大学 Mutagenesis method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOYCE CHIU ET AL: "Site-directed, Ligase-Independent Mutagenesis (SLIM) for highly efficient mutagenesis of plasmids greater than 8kb", 《JOURNAL OF MICROBIOLOGICAL METHODS》 *

Similar Documents

Publication Publication Date Title
US20240117330A1 (en) Enzymes with ruvc domains
US10982200B2 (en) Enzymes with RuvC domains
CN107922931A (en) Heat-staple Cas9 nucleases
CN108277231B (en) CRISPR system for corynebacterium genome editing
EP4146800A1 (en) Enzymes with ruvc domains
Sung et al. Combining orthogonal CRISPR and CRISPRi systems for genome engineering and metabolic pathway modulation in Escherichia coli
US11946039B2 (en) Class II, type II CRISPR systems
CN110373370B (en) Catalytic system coupled with ATP regeneration system and application of catalytic system in glutathione production process
CN106755037A (en) A kind of Virginia streptomycete IBL14 type I B sv14 type CAS gene editing systems
CA3192224A1 (en) Base editing enzymes
Kouprina et al. Highly selective, CRISPR/Cas9‐mediated isolation of genes and genomic loci from complex genomes by TAR cloning in yeast
WO2023097282A1 (en) Endonuclease systems
CN109385417A (en) Internal DNA seamless integration method
Wang et al. Highly efficient CRISPR-mediated base editing in Sinorhizobium meliloti
US20220298494A1 (en) Enzymes with ruvc domains
CN104404029A (en) Mutation method based on methylation circular DNA molecules
WO2023076952A1 (en) Enzymes with hepn domains
CN103540587B (en) Targeted integration exogenous DNA array is to the method in rat and mouse Rosa26 site and application thereof
CN108486140A (en) A kind of cloning vector preparation method and kit based on seamless clone technology
CN104404073A (en) Mutation kit based on methylation circular DNA molecules and application of mutation kit based on methylation circular DNA molecules
Walker et al. A method for generating sticky-end PCR products which facilitates unidirectional cloning and the one-step assembly of complex DNA constructs
EP4165177A1 (en) Enzymes with ruvc domains
CN104805108B (en) A kind of fast construction method of high copy gene multiple repeats
RU2797049C1 (en) Genome editing tool based on ligd protein from the bacterium pseudomonas putida and cas9 complex
GB2617659A (en) Enzymes with RUVC domains

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150311